- Home
- FSV vs ROIV Comparison
FSV vs ROIV Comparison
Compare FSV & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSV
- ROIV
- Stock Information
- Founded
- FSV 1988
- ROIV 2014
- Country
- FSV Canada
- ROIV United Kingdom
- Employees
- FSV N/A
- ROIV N/A
- Industry
- FSV Real Estate
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- FSV Finance
- ROIV Health Care
- Exchange
- FSV Nasdaq
- ROIV Nasdaq
- Market Cap
- FSV 7.8B
- ROIV 8.4B
- IPO Year
- FSV N/A
- ROIV N/A
- Fundamental
- Price
- FSV $175.61
- ROIV $10.76
- Analyst Decision
- FSV Buy
- ROIV Buy
- Analyst Count
- FSV 5
- ROIV 4
- Target Price
- FSV $203.00
- ROIV $17.50
- AVG Volume (30 Days)
- FSV 101.8K
- ROIV 5.8M
- Earning Date
- FSV 04-24-2025
- ROIV 05-29-2025
- Dividend Yield
- FSV 0.63%
- ROIV N/A
- EPS Growth
- FSV 42.94
- ROIV N/A
- EPS
- FSV 2.88
- ROIV N/A
- Revenue
- FSV $5,309,675,000.00
- ROIV $122,585,000.00
- Revenue This Year
- FSV $7.67
- ROIV N/A
- Revenue Next Year
- FSV $6.82
- ROIV N/A
- P/E Ratio
- FSV $61.01
- ROIV N/A
- Revenue Growth
- FSV 18.68
- ROIV 140.04
- 52 Week Low
- FSV $141.26
- ROIV $8.73
- 52 Week High
- FSV $197.84
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- FSV 55.83
- ROIV 49.48
- Support Level
- FSV $171.01
- ROIV $10.58
- Resistance Level
- FSV $177.89
- ROIV $11.77
- Average True Range (ATR)
- FSV 3.01
- ROIV 0.34
- MACD
- FSV -0.03
- ROIV -0.08
- Stochastic Oscillator
- FSV 71.85
- ROIV 15.13
About FSV FirstService Corporation
FirstService Corp operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high-, medium-, and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertPro Painters; Pillar to Post; Floor Coverings International; College Pro Painters; and Service America. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.